RNA-Seq is becoming the tool of choice for gene expression studies, as it can facilitate the investigation of phenomena beyond the reach of traditional microarrays, such as novel transcripts and isoforms, alternative splice sites, and allele-specific expression. However, this increased power comes with orders of magnitude higher complexity in terms of bioinformatics, data storage, and processing.
Prognosys Biosciences announced Voila!™, a new cloud-based data analysis service for next-generation sequencing data. Voila! will be available initially for RNA sequencing projects that utilize data from Illumina HiSeq and GAIIx next-generation sequencing instruments.
Golden Helix and Expression Analysis announced they will be developing a cloud-based analytic solution to increase adoption of RNA sequencing. Bioinformatic processes will be performed in a service-based cloud compute environment. This offering will address the obstacles of sequence data by providing cloud-based and integrated desktop analysis tools that are scalable, affordable, and simplified.
Appistry, Inc. announced the release of a series of advanced RNA-Seq solutions for the rapid analysis of sequencing data generated by this emerging technology. The TopHat, TopHat-Fusion and MapSplice-based solutions leverage the Ayrris/BIO(TM) high-performance computing platform to foster Personalized Medicine approaches by enabling researchers to process and analyze large volumes of data in a fraction of the time currently required by conventional gene expression profiling technologies. The RNA-Seq solutions were developed by the Appistry Life Sciences Group–recently established to conceptualize and deliver technologies for Next Generation Sequencing.